drug development

Exscientia Shifts Focus: Consolidates ‘Rapidly Emerging Pipeline’ to Emphasize 2 Key Oncology Programs

Exscientia, an AI-driven precision medicine company, is streamlining its pipeline to concentrate on the highest-value opportunities. The company is focusing ...